VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
191 hedge funds and large institutions have $657M invested in Meridian Bioscience Inc in 2020 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 65 increasing their positions, 59 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
–
Holders Change %
0%
% of All Funds
3.86%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
37
Increased
65
Reduced
59
Closed
34
Calls
$2.7M
Puts
$1.65M
Net Calls
+$1.05M
Net Calls Change
-$1.76M
Top Buyers
| 1 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
+$4.9M |
| 2 |
RA
Royce & Associates
New York
|
+$4.21M |
| 3 |
CEI
Clark Estates Inc
New York
|
+$3.74M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$3.48M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.42M |
Top Sellers
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$5.96M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.9M |
| 3 |
Renaissance Technologies
New York
|
-$4.59M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$3.41M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.95M |
